BioSpace

US biotechs take lion’s share of $54.5B VC money raised since 2025

Since 2025, U.S. biopharma companies have raised $37.2 billion—68% of total worldwide venture capital funding in the industry—with startups in the San Francisco Bay Area and Boston leading the way.

By BioSpace

1 min read
US biotechs take lion’s share of $54.5B VC money raised since 2025
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights